Zymergen Hires Former Apple Executive and Ford Motor Leader as Chief Manufacturing Officer prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share on Twitter
Melbourne Victory s 5-4 win over Western Sydney on Friday means Craig Deans team face Western at AAMI Park a point adrift at the basement of the competition, having failed to win in their past nine outings.
Koutroumbis and Boogaard have not featured since the home defeat to Adelaide in late March but Deans said both players, as well as Josh Hoffman (groin), were in contention to feature on Monday night. Johnny is probably a little bit closer than Nige, Deans said.
Read More Nige is pushing himself hard . they ve got a great attitude to their rehab and their professionalism away from the field, so they are probably a week or two ahead of schedule.
In An Earth Day Test For Synthetic Biology Field, Zymergen Raises $500 Million In IPO
CLINTON PERRY PHOTOGRAPHY 2019
The past few years have been boom times for synthetic biology. Today, in a big test for public markets’ appetite for the emerging field, Zymergen raised $500 million in an initial public offering set to value the company at more than $3 billion.
“I love the symbolism that we’re going public on Earth Day,” cofounder and CEO Josh Hoffman told
Forbes in a morning video call. “There’s a bit of luck there, but I’m just super pleased. It is really cool.”
Hoffman, 50, a former McKinsey consultant and Rothschild merchant banker, founded Zymergen in 2013 with two former Amyris execs, Zach Serber, 46, now chief science officer, and Jed Dean, 43, now vp of of operations and engineering. They named it Zymergen as a mash-up of the words zymurgy (the study of fermentation), merge and genomics. Based in Emeryville, California, a hotspot for biology startups, the
Bluerock Residential Growth REIT (BRG) First Quarter 2021 Earnings
- Conference Call Set for May 10 -
News provided by
Share this article
Share this article
NEW YORK, April 15, 2021 /PRNewswire/ Bluerock Residential Growth REIT, Inc. (NYSE: BRG) will release its financial results for the first quarter ended March 31, 2021 before the market opens on Monday, May 10, 2021. The Company will host a conference call to discuss its financial results on Monday, May 10, 2021 at 11:00 AM (Eastern Time). The call will include prepared remarks by management as well as a question and answer session.
Conference Call Details
Investors and analysts may pre-register for the webcast to receive a unique PIN to gain immediate access to the call and bypass the live operator. Pre-registration may be completed at any time, including up to and after the call start time, by accessing https://dpregister.com/sreg/10155057/e6f3fb545f.
Industry Pioneer Jay Flatley Named as Chairman of Zymergen Board of Directors
Brings decades of leadership in high-growth biotechnology and sciences companies
News provided by
Share this article
Jay Flatley as the Chairman of the Board of Directors, effective immediately. Jay has served as lead Independent Director on Zymergen s board since late 2019. Over the last 8 years, we ve built a powerful biofacturing platform and excellent customer relationships in our key verticals, said Zymergen CEO, Josh Hoffman. As we mature as a company, we are strengthening our Board and governance practices. With that backdrop, I am delighted to announce that Jay Flatley has been appointed to serve as Chairman of Zymergen s Board of Directors.